Peer Review History
| Original SubmissionNovember 9, 2019 |
|---|
|
PONE-D-19-31286 Haemoglobin level as an indicator of health status of school-aged children in Muyuka, Southwest Cameroon: Influence of malaria parasites, soil-transmitted helminths and malnutrition PLOS ONE Dear Dr. Sumbele, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Jan 11 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Hesham Hesham M. Al-Mekhlafi, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found athttp://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please address the following: - Please refer to any post-hoc corrections to correct for multiple comparisons during your statistical analyses. If these were not performed please justify the reasons. Please refer to our statistical reporting guidelines for assistance (https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting). - Please ensure you have thoroughly discussed any potential limitations of this study within the Discussion section, for example the potential bias introduced by using self-reported data. - Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. In addition, please include any details of the pre-testing of this questionnaire. Thank you for your attention to our queries. 3. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I read the manuscript with great interest. The manuscript was very interesting and provided good information on the Hemoglobin level as an indicator of health status of school-aged children. However, it has some points that need to be addressed to improve its quality and impact. Here are some of my observations: The map for the target area should be included in the manuscript. The references were mostly from more than 5 years ago. If possible, add more recent references. Reviewer #2: Dear Editor I have thoroughly read the manuscript, although it represents an important public health problem in School Aged Children it has a number of issues in literature review, statistical analysis and discussion. The jauthors should revise the manuscript by addressing a number of typographical, data presentation and discussion before it is considered for publication. I have highlighted a number of issues in the attached revised doc Reviewer #3: Review for Manuscript Entitled “Haemoglobin level as an indicator of health status of school-aged children in Muyuka, Southwest Cameroon: Influence of malaria parasites, soil-transmitted helminths and malnutrition” Abstract Background • Line 60- You mention an abbreviation SAC without prior statement of its long form. Much as it is appearing for the first time in the background section it has to be in its long form, and then can subsequently be mentioned as a acronym. • Line 98- Put a percent symbol after 64.3 • Line 99-Put a percent symbol after 19.8 • Line 100-Indicate the specific threshold at which anaemia is considered a public health problem Methodology Study site The description of the study site need to have a reference, no reference is provided for the description of the study site, kindly provide the reference. Study design • After stating the study design, for the purpose of making the paper easy to follow by the reader, this section should have the following subsections: • Study population • Sample size • Sampling procedure • In this paper, the primary objective was to determine the prevalence of Malaria parasite, STH and Malnutrition. But in calculating the sample size you used 14.0% which was the prevalence of STH, but you have not indicated that this is what is going to give enough sample size to estimate the population prevalence of Malaria parasites and Malnutrition as well. • Line 146-148: You state that “The minimum sample size was calculated using the prevalence of P. falciparum malaria and helminth infections of previous studies: 35.5 and 14.0%, respectively, in the Mount Cameroon area”. But the formular for sample size calculation that you have provided allows for using only one proportion, how did you use these two proportions? • But after you have calculated the sample size, you have not indicated in this section what was the calculated minimum sample size. • Line 152-154: “Samples collected comprised of finger prick blood and stool for MP detection and speciation, Hb 153 measurement for assessment of anaemia and detection of egg or larva of STHs respectively” , rephrase this statement to make it clear as to which sample was used for whic purpose. Clinical evaluation • Line 172: You have written o.1cm instead of 0.1, kindly change accordingly. Collection of blood and stool samples • Line 192: Samples were fixed in 10% formalin and then examined using the Kato-katz technique, can the author explain, how did they perform kato-katz on a formalin fixed stool, Kato-katz performs well when done on fresh stool. Can you explain this? • Line 194: You have written Kato-katz concentration technique. Kato-katz is not one of the concentration techniques applied on stool samples. Statistical analysis Line 228: SPSS is no longer Statistical Package for Social Sciences, please supply the correct long form. Results Characteristics of the study participants • In this subsection you were supposed to provide only socio-demographic and economic profile of the study participants. But you have also provided findings from laboratory analysis and other measurements, these should fall under a separate subheading and a separate table. • Line 260-261: Out of 9 children with STH, 55.5% were infected with Trichuris trichiura, please indicate both the number and percentages. Anaemia prevalence and its severity • When writing confidence interval, you must indicate that it is 95% CI, do not just write “CI” as it appears in line 293, 301, 302 etc. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Associate Professor Dr. Talal Alharazi Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-19-31286R1 Haemoglobin level as an indicator of health status of school-aged children in Muyuka, Southwest Cameroon: Influence of malaria parasites, soil-transmitted helminths and malnutrition PLOS ONE Dear Dr. Sumbele, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Mar 14 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Hesham Hesham M. Al-Mekhlafi, PhD Academic Editor PLOS ONE Additional Editor Comments (if provided): Academic Editor’s Comments: Dear authors, Thank you for submitting your revised manuscript to PLoS One. This version has addressed the reviewers’ comments; however, corrections remain and additional comments should be addressed before this manuscript can be accepted. Please consider the following: 1- In laboratory procedures section, it is mentioned that malaria parasite density per μL of blood was determined; however, information on this variable was not provided in the manuscript. Using the term “malaria parasitaemia” in the current manuscript without providing these results is unclear and can be misleading. It can be replaced with malaria infection. Moreover, it is interesting to examine the association between the level of parasitaemia (parasite density) and Hb level and anaemia prevalence as well, and this should be incorporated into the results & discussion of this manuscript. 2- The attributable risk (AR%) was mentioned in statistical analysis section (please remove details on formula used) and in discussion and conclusion; however, results were not provided in results section.! 3- I suggest change the title. Presentation of your results and your conclusion are not compatible with the title “Haemoglobin level as an indicator of health status of ….”. Basically, the title can be “Influence of malaria, soil-transmitted helminth infections and malnutrition on haemoglobin level and anaemia prevalence among school-aged children in Muyuka, Southwest Cameroon”. You may think about alternative titles. 4- Tables format should be improved and edited for consistency and English. For instance: 4.1. Table 5: change columns of total to “overall mean (SD) Hb level” and this column can be placed after prevalence o anaemia column. P-value for sex can be placed after the columns of mean Hb for sex and p-value for age groups will be accordingly after the columns of age. Indicate the use of t-test and ANOVA in the footnotes. 4.2. Table 3: the data are % (n) but it is indicated as (n) only. 4.3. Table 6: please report important necessary results only for the output of MLR analysis; collinearity statistics and correlation coefficient columns can be removed. Please read about reporting such results in scientific papers or refer to previous literature. For instance, provide B value, standard error, 95% CI and p value for the included variables. 5- Figure 2 can be removed. Renumber the figures. 6- What is URIT-12 haemoglobin meter? Company, City, Country, and cite reference for its validity. 7- Follow first appearance rule; for instance, spell out the MUAC in abstract and then add the abbreviation between brackets. Follow this in the entire text and tables. In tables, define the abbreviations in the footnotes. 8- Moreover, the manuscript needs extensive editing by a native English speaker. Please note that poor English may ultimately be a reason to reject the manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: No Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The authors have adequately addressed all my comments. However, proof reading of the manuscript is needed before publication Reviewer #3: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Influence of malaria, soil-transmitted helminths and malnutrition on haemoglobin level among school-aged children in Muyuka, Southwest Cameroon: a cross-sectional study on outcomes PONE-D-19-31286R2 Dear Dr. Sumbele, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Hesham Hesham M. Al-Mekhlafi, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Please note that weight and height values (mean and range) in Table 2 are in opposite order. To correct this, variable names should be exchanged. This can be corrected prior to the production stage. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-19-31286R2 Influence of malaria, soil-transmitted helminths and malnutrition on haemoglobin level among school-aged children in Muyuka, Southwest Cameroon: a cross-sectional study on outcomes Dear Dr. Sumbele: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Hesham M. Al-Mekhlafi Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .